Ilyang Pharmaceutical Co Ltd (007575) - Total Liabilities

Latest as of June 2025: ₩205.41 Billion KRW ≈ $139.20 Million USD

Based on the latest financial reports, Ilyang Pharmaceutical Co Ltd (007575) has total liabilities worth ₩205.41 Billion KRW (≈ $139.20 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 007575 cash flow metrics to assess how effectively this company generates cash.

Ilyang Pharmaceutical Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Ilyang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Ilyang Pharmaceutical Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Ilyang Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Ilyang Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kao Fong Machinery Co Ltd TWO:4510	Taiwan	NT$4.82 Billion
Clavister Holding AB (publ.) ST:CLAV	Sweden	Skr348.76 Million
BICO Group AB ST:BICO	Sweden	Skr1.93 Billion
Mayne Pharma Group Ltd AU:MYX	Australia	AU$644.32 Million
UmweltBank AG XETRA:UBK	Germany	€-417.13 Million
Muhak Co. Ltd KO:033920	Korea	₩105.07 Billion
Orogen Royalties Inc V:OGN	Canada	CA$1.99 Million
Unisys Corporation NYSE:UIS	USA	$2.03 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Ilyang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ilyang Pharmaceutical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.87	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.87	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ilyang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ilyang Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual total liabilities of Ilyang Pharmaceutical Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩189.63 Billion ≈ $128.51 Million	+18.33%
2023-12-31	₩160.25 Billion ≈ $108.60 Million	-22.33%
2022-12-31	₩206.33 Billion ≈ $139.83 Million	-7.27%
2021-12-31	₩222.51 Billion ≈ $150.79 Million	+14.58%
2020-12-31	₩194.19 Billion ≈ $131.60 Million	-9.56%
2019-12-31	₩214.72 Billion ≈ $145.51 Million	-3.44%
2018-12-31	₩222.37 Billion ≈ $150.70 Million	-1.34%
2017-12-31	₩225.39 Billion ≈ $152.74 Million	+5.37%
2016-12-31	₩213.91 Billion ≈ $144.96 Million	-3.04%
2015-12-31	₩220.62 Billion ≈ $149.51 Million	-10.81%
2014-12-31	₩247.37 Billion ≈ $167.64 Million	--

About Ilyang Pharmaceutical Co Ltd

KO:007575 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$159.79 Million

₩235.79 Billion KRW

Market Cap Rank

#17373 Global

#797 in Korea

Share Price

₩12980.00

Change (1 day)

+0.00%

52-Week Range

₩12320.00 - ₩15550.00

All Time High

₩141909.13